Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific LSE:NSCI London Ordinary Share GB00B9F4MT28 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -0.81% 61.50p 59.00p 64.00p 62.00p 61.50p 62.00p 4,920.00 09:00:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.1 -11.3 -28.4 - 31.41

Netscientific Share Discussion Threads

Showing 626 to 648 of 650 messages
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
16/2/2017
12:29
However i bet my dad can fight your dad!Pathetic. Give it a rest you two.
beeks of arabia
16/2/2017
12:28
Oh really? No doubt you know, as I posted nearly all my trades from August last year to December as they happened on advfn - they are there for all to see - posted upfront - so you can see where and how I made profits. I'm contrarian, unlike you who follows Zengas, I call it out the way I see it. I'm honest enough to say when I make mistakes, you of course never make mistakes. BTW, I don't recall ever calling this out as a sell as I'm not qualified to give financial advice - if I did however, it might have saved horrendous losses for some.
che7win
16/2/2017
01:37
Meanwhile NSCI holding firm the past few days - looks like Chewin was advising selling yet another stock at the very bottom. He really is a perfect contrarian signal.
yasx
16/2/2017
01:36
Well, funny you mention Zengas - I have never followed him into anything. Indeed, why don't you ask Zengas what I told him about TRIN at 2p last summer and why he should be buying. I do not publish confidential messages, but, if he wishes to clarify he can do so. Indeed, he reminded me recently in a private message that it was a tremendous call, and I again at 8p told him that we were still at the foothills. He agreed, and though he will surely assess things for himself rather than rely on me, he will confirm I put Trinity to him not the other way around. As for HNR, again I was the first to spot the potential for price appreciation - but, I very early realised it was not quite what it purported to be and sold banking a good gain - it carried on much higher, but I buy value, not speculative price spikes. Off you go - select some of your own picks and stop this obsession with this gracious chap. You see, you need to read my thoughts, not vice versa. Some lead, others follow. Hope that helps.
yasx
15/2/2017
19:58
Oh dear, I'm doing very well thank you. We all know you follow Zengas around. You followed him into HNR at 20p, sold out too early and watched it quadruple - with you left behind.
che7win
15/2/2017
19:05
Chewin simply follows me around - it is no coincidence that wherever I appear, he follows. I took Trinity just prior to suspension and since resumption of trading have been shouting from the rooftops about the undervaluation, taking yet more still at just over 6p. Coincidentally, Chewin is now a fan of that too. I have produced detailed analysis on it applauded by many readers, whereas this nut has done no analysis other than declaring some curved bottom or just buying because I have. His top pick for the decade was Iofina at 200p, on which he placed a £150 target. I jest not. Oh dear. What a hopeless plum.
yasx
15/2/2017
10:39
There we go, Trin just moved up 10%
che7win
15/2/2017
09:58
Escape, Sellers have readily been able to get 60p for days even with the spread noted as 58-63p. But, try buying a significant line.... one will likely have to pay at least 70p.
yasx
15/2/2017
09:57
Escape, Would you not be better buying TRIN?
che7win
15/2/2017
08:58
Yes, 6% spread immediately you buy.
che7win
15/2/2017
08:38
Had a top up but it cost me , 63.5 p or something like that , where the bid was much lower.
escapetohome
15/2/2017
07:17
A prestigious award, great recognition chaps.
che7win
13/2/2017
12:30
che7win little heads up runawaypaul/loveandmoney1/purple11 are all the same person. Paul tends to use all three when on a pump and dump mission.
tradermick1
12/2/2017
10:19
https://www.youtube.com/watch?v=RBumgq5yVrA#t=162 https://twitter.com/paulkeys5
runwaypaul
11/2/2017
16:52
Intuitive then. Same as me. Just wondered.............
keyno
11/2/2017
16:52
Escape, Neither, though I have a robust understanding of both. Most of my investments are in the oil/gas/mining space, normally largecaps, and normally I am bearish, hence most of my calls are of a bearish tilt.
yasx
11/2/2017
16:50
Keyno, Does Buffett have retail qualifications? Or does he hold qualifications relating to the Transport industry? No, but he has made substantial investments and profits from the same. How any fund managers or analysts covering mining companies are geologists or mining engineers? How many covering the steel industry are metallurgists? Does Woodford hold medical or pharmaceutical qualifications to enable him to run his healthcare fund? I think you get the point. It is about understanding investment, not the minutiae of the industry to which the underlying investment relates
yasx
11/2/2017
16:21
To be frank my impression is Mr Yasx operates in the legal rather than medical / scientific field.
escapetohome
11/2/2017
16:05
yasX: I would be interested to know what scientific qualifications you have or whether your assessments are more intuitive. I bought in here high, always with a view to averaging down if I felt it was "worth it" and if I was being pessimistic. I have yet to be convinced that my money would not be better spent elsewhere and have not bought any more shares here.
keyno
11/2/2017
15:52
Chuckle chuckle indeed, ishall top up here , a few hundred pounds more! Yup i trusted the iof crowd too much and got burnt, not badly , now i am cautious with my money and spread my risk. My iof loss amounted to around £10,000. Thanks yasx.
escapetohome
11/2/2017
15:48
I trust that is the prelude to the 'robust piece' we have been promised this weekend?
runwaypaul
11/2/2017
15:10
Escape, Some of these portfolio companies are at a very nascent stage, others reaching the point of commercialisation - thus, one cannot reliably value this on the basis of current earnings. For instance, as I explained in a previous post, just one of the portfolio companies is expected to generate some 300 million within a decade. It is plainly silly to value technology or biotech companies based on existing earnings, since, the majority will have nil or negligible earnings for years to come. NSCI is at a ore advanced stage, but it is still early days. What you need to do is to assess the capability of the projects/assets to generate revenues down the line. In order to do this, you need to understand the products, their advantages, the marketplace, competitors and so on. That is what Woodford has done, hence why he took over 40c of the company at prices of 120p and more. He, like this gracious chap, is taking the longer term view,and I maintain the rewards will be considerable. This is not Iofina, a basket case if ever there was one. Nor is it IDP, selling some fake tan in a few retail stores with no development potential and a price to earnings ratio of about a billion - chuckle chuckle!
yasx
11/2/2017
14:59
Hello Yasx , which of the underwing companies is bringing in the most revenue right now and what is that revenue? Some of these underwing companies seem a little wishy washy, perphaps a little bit too much ' jam tommorow ' for the gracious chap?
escapetohome
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20170220 10:59:12